Lanean...
CRMP2 phosphorylation drives glioblastoma cell proliferation
Glioblastoma (GBM) is an aggressive primary brain tumor. The rapid growth and the privileged provenance of the tumor within the brain contribute to its aggressivity and poor therapeutic targeting. A poor prognostic factor in glioblastoma is the deletion or mutation of the Nf1 gene. This gene codes f...
Gorde:
| Argitaratua izan da: | Mol Neurobiol |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5745298/ https://ncbi.nlm.nih.gov/pubmed/28660485 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12035-017-0653-9 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|